Genmab A/S
GMAB
$23.424+0.11 (+0.49%)
Aug 18, 2025, 3:21 PM
Financials
| 52Week High | 1,893.00 | 52Week Low | 1,157.00 |
| Beta | 0.45 | Current Ratio Annual | 5.25 |
| Current Ratio Quarterly | 5.34 | Gross Margin TTM | 42.34 |
| Market Cap | 89.71B | Net Profit Margin TTM | 13.27 |
| Operating Margin TTM | 13.78 | Price To Book | 16.94 |
| Price To Earnings TTM | 37.35 | Price To Free Cash Flow TTM | 42.01 |
| Price To Sales TTM | 4.96 | Quick Ratio Annual | 5.24 |
| Quick Ratio Quarterly | 5.32 | Return On Assets TTM | 16.40 |
| Return On Equity TTM | 20.45 | Return On Investment TTM | 19.82 |
| Revenue Growth3Y | 36.40 | Revenue Growth5Y | 32.03 |
| Revenue Growth Quarterly Yoy | -82.74 | Revenue Growth TTMYoy | 1.89 |
| Revenue Per Share TTM | 283.07 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 230 | 2 | 0 | 6 | 1 | 0 | 61M | $1.26B |
| Mar 31, 2025 | 220(-4%) | 35(+1650%) | 42(+%) | 92(+1433%) | 63(+6200%) | 24(+%) | 65.99M(+8%) | $1.29B(+2%) |
| Jun 30, 2025 | 215(-2%) | 22(-37%) | 35(-17%) | 83(-10%) | 71(+13%) | 23(-4%) | 61.08M(-7%) | $1.26B(-2%) |